This gas station drug acts like opioids. It’s getting harder to buy
Nov 20, 2026 · 14m
More Science podcasts · More News podcasts
Summary
NPR science reporter Rachel Carlson explores the growing market for Kratom and 7-OH products, which are sold as pain relief or opioid withdrawal aids but carry significant addiction risks. The episode features personal stories from users who developed severe dependencies, alongside expert insights on the dangers of unregulated, poorly labeled substances. It also covers recent DEA moves to restrict specific semi-synthetic derivatives, highlighting the ongoing tension between public health concerns and the lack of federal oversight for natural Kratom.
Topics discussed
Sponsor: Citi Premium Boost
Introduction to Kratom and 7-OH products
Tyler's story: Using Kratom for opioid withdrawal
Tyler's experience with 7-OH tablets and addiction
Episode overview and host introductions
Sponsors: Whole Foods, Citi, and Open Door
Reflection on Tyler's detox and accessibility
Brian's story: Discovering Kratom at a gas station
Brian's transition to 7-OH and addiction
Angela's positive experience managing pain
Scientific perspective on addiction patterns
The high cost of 7-OH usage
Rising poison control calls and deaths
Concerns over labeling and product dosing
Federal regulation and DEA restrictions
Pushback from users and industry lobbying
Credits and closing remarks
Sponsor: Schwab
Sponsor: Prolon
More from Short Wave
Listen ad-free on Castria